Australian Statistics on Medicines 2011
Table 1 - Antineoplastic and Immunomodulating Agents
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||||
L01AA02 |
CHLORAMBUCIL |
||||||
P |
1163F |
Tablet 2mg |
- |
- |
3,068 |
372,900 |
|
L01AA01 |
CYCLOPHOSPHAMIDE |
||||||
P |
1031G |
Injection 2g (solvent required) |
- |
- |
10,305 |
595,376 |
|
P |
1079T |
Injection 500mg (solvent required) |
- |
- |
4,971 |
201,630 |
|
P |
1080W |
Injection 1g (solvent required) |
- |
- |
5,709 |
192,735 |
|
P |
1266P |
Tablet 50mg |
- |
- |
9,464 |
283,840 |
|
P |
5914G |
Injection 500mg (solvent required) |
- |
- |
3,419 |
56,188 |
|
P |
5915H |
Injection 1g (solvent required) |
- |
- |
5,570 |
118,352 |
|
P |
5916J |
Injection 2g (solvent required) |
- |
- |
2,201 |
93,473 |
|
P |
6704W |
Injection 500 mg 10mL and NS |
- |
- |
735 |
32,919 |
|
P |
6710E |
Injection 1g 10mL and NS |
- |
- |
1,483 |
54,623 |
|
P |
7055H |
Injection 2g 10mL and NS |
- |
- |
1,311 |
78,212 |
|
L01AA06 |
IFOSFAMIDE |
||||||
P |
5943T |
Powder for I.V. injection 1g |
- |
- |
290 |
52,229 |
|
P |
5944W |
Powder for I.V. injection 2g |
- |
- |
228 |
78,973 |
|
P |
8076C |
Powder for I.V. injection 1g |
- |
- |
465 |
168,874 |
|
P |
8077D |
Powder for I.V. injection 2g |
- |
- |
1,042 |
658,563 |
|
L01AA03 |
MELPHALAN |
||||||
P |
2547C |
Tablet 2mg |
- |
- |
3,036 |
146,900 |
|
ALKYL SULPHONATES |
|||||||
L01AB01 |
BUSULPHAN |
||||||
P |
1128J |
Tablet 2mg |
- |
- |
386 |
33,004 |
|
NITROSOUREAS |
|||||||
L01AD05 |
FOTEMUSTINE |
||||||
P |
5900M |
Powder for injection 208mg with solvent |
- |
- |
193 |
209,276 |
|
P |
8786K |
Powder for injection 208mg with solvent |
- |
- |
619 |
910,890 |
|
OTHER ALKYLATING AGENTS |
|||||||
L01AX03 |
TEMOZOLOMIDE |
||||||
P |
8378Y |
Capsule 5mg |
- |
- |
226 |
64,760 |
|
P |
8379B |
Capsule 20mg 5 |
- |
- |
1,051 |
724,208 |
|
P |
8380C |
Capsule 100mg 5 |
- |
- |
4,612 |
11,289,113 |
|
P |
8381D |
Capsule 250mg 5 |
- |
- |
1,517 |
2,820,846 |
|
P |
8819E |
Capsule 5mg 15 |
- |
- |
318 |
126,903 |
|
P |
8820F |
Capsule 20mg 15 |
- |
- |
425 |
294,492 |
|
P |
8821G |
Capsule 100mg 15 |
- |
- |
658 |
1,665,408 |
|
P |
9361Q |
Capsule 140mg 15 |
- |
- |
1,103 |
3,719,077 |
|
P |
9362R |
Capsule 140mg 5 |
- |
- |
1,516 |
3,978,846 |
|
ANTIMETABOLITES |
|||||||
FOLIC ACID ANALOGUES |
|||||||
L01BA01 |
METHOTREXATE |
||||||
P |
1622J |
Tablet 2.5mg |
- |
- |
62,435 |
814,485 |
|
ANTIMETABOLITES |
|||||||
P |
1623K |
Tablet 10mg |
- |
- |
117,068 |
5,254,740 |
|
P |
2272N |
Tablet 10mg 15 |
- |
- |
38,236 |
831,937 |
|
P |
2395C |
Injection 50mg in 2mL |
- |
- |
18,046 |
641,138 |
|
P |
2396D |
Injection 5mg in 2mL |
- |
- |
1,620 |
118,413 |
|
P |
5875F |
Solution concentrate I.V. infusion 1000mg in 10mL |
- |
- |
202 |
19,090 |
|
P |
5962T |
Injection 5mg in 2mL |
- |
- |
793 |
12,486 |
|
P |
5963W |
Injection 50mg in 2mL |
- |
- |
312 |
5,320 |
|
P |
8851W |
Solution concentrate I.V. infusion 1000mg in 10mL |
- |
- |
410 |
93,989 |
|
P |
8852X |
Solution concentrate I.V. infusion 5000mg in 50mL |
- |
- |
249 |
150,647 |
|
P |
8863L |
Solution concentrate I.V. infusion 500mg in 20mL |
- |
- |
173 |
14,399 |
|
L01BA04 |
PEMETREXED |
||||||
P |
5834C |
Powder for I.V. infusion 500mg (base) 2 |
- |
- |
3,699 |
5,801,119 |
|
P |
5835D |
Powder for I.V. infusion 100mg (base) 1 |
- |
- |
2,205 |
1,272,526 |
|
P |
9130M |
Powder for I.V. infusion 500mg (base) 2 |
- |
- |
5,173 |
9,553,207 |
|
P |
9131N |
Powder for I.V. infusion 100mg (base) 1 |
- |
- |
6,000 |
11,872,504 |
|
L01BA03 |
RALTITREXED |
||||||
P |
8284B |
Powder for I.V. infusion 2mg |
- |
- |
248 |
209,443 |
|
PURINE ANALOGUES |
|||||||
L01BB05 |
FLUDARABINE |
||||||
P |
5840J |
Powder for I.V. injection 50mg 5 |
- |
- |
255 |
135,186 |
|
P |
5841K |
Solution for I.V. injection 50mg in 2mL 5 |
- |
- |
227 |
114,624 |
|
P |
9184J |
Tablet 10mg 20 |
- |
- |
807 |
773,506 |
|
P |
9185K |
Powder for I.V. injection 50mg 5 |
- |
- |
493 |
644,120 |
|
P |
9207N |
Solution for I.V. injection 50mg in 2mL 5 |
- |
- |
256 |
320,852 |
|
L01BB02 |
MERCAPTOPURINE |
||||||
P |
1598D |
Tablet 50mg |
- |
- |
20,884 |
5,112,990 |
|
L01BB03 |
THIOGUANINE |
||||||
P |
1233X |
Tablet 40mg |
- |
- |
648 |
172,405 |
|
PYRIMIDINE ANALOGUES |
|||||||
L01BC07 |
AZACITIDINE |
||||||
P |
6100C |
Powder for injection 100mg |
- |
- |
379 |
2,924,159 |
|
P |
6138C |
Powder for injection 100mg |
- |
- |
290 |
2,193,399 |
|
L01BC06 |
CAPECITABINE |
||||||
P |
8361C |
Tablet 150mg |
- |
- |
1,732 |
240,190 |
|
P |
8362D |
Tablet 500mg 120 |
- |
- |
29,034 |
20,599,474 |
|
L01BC01 |
CYTARABINE |
||||||
P |
2884T |
Injection set containing 100mg and 5mL solvent |
- |
- |
1,516 |
946,122 |
|
P |
5918L |
Injection set containing 100mg and 5mL solvent |
- |
- |
643 |
46,978 |
|
L01BC02 |
FLUOROURACIL |
||||||
P |
2528C |
Injection 500mg in 10mL |
- |
- |
35,672 |
1,947,236 |
|
P |
4222F |
Cream 50mg per g (5%) 20g |
- |
- |
101,789 |
5,685,649 |
|
P |
5808Q |
Injection 5000mg in 100mL 1 |
- |
- |
169 |
5,863 |
|
P |
5872C |
Injection 1000mg in 20mL 5 |
- |
- |
9,548 |
248,202 |
|
ANTIMETABOLITES |
|||||||
P |
5935J |
Injection 500mg in 10mL |
- |
- |
11,697 |
337,206 |
|
P |
8995K |
Injection 2500mg in 50mL 2 |
- |
- |
151 |
6,719 |
|
P |
8996L |
Injection 5000mg in 100mL 1 |
- |
- |
238 |
11,656 |
|
P |
9005Y |
Injection 1000mg in 20mL 5 |
- |
- |
12,363 |
602,946 |
|
L01BC05 |
GEMCITABINE |
||||||
P |
5843M |
Solution concentrate for I.V. infusion 200mg (base) in 20mL |
- |
- |
164 |
16,786 |
|
P |
5844N |
Solution concentrate for I.V. infusion 1000mg (base) in 100mL |
- |
- |
635 |
141,110 |
|
P |
5845P |
Solution concentrate for I.V. infusion 2gm (base) |
- |
- |
854 |
280,144 |
|
P |
5852B |
Solution concentrate for I.V. infusion 500mg (base) in 50mL 4 |
- |
- |
290 |
35,756 |
|
P |
5936K |
Powder for I.V. infusion 200mg (base) |
- |
- |
4,803 |
463,119 |
|
P |
5937L |
Powder for I.V. infusion 1gm (base) |
- |
- |
7,388 |
1,636,951 |
|
P |
8049P |
Powder for I.V. infusion 200mg (base) |
- |
- |
4,735 |
1,611,400 |
|
P |
8050Q |
Powder for I.V. infusion 1gm (base) |
- |
- |
10,584 |
6,093,187 |
|
P |
9401T |
Solution concentrate for I.V. infusion 200mg (base) in 20mL |
- |
- |
1,056 |
334,105 |
|
P |
9402W |
Solution concentrate for I.V. infusion 1000mg (base) in 100mL |
- |
- |
1,232 |
657,100 |
|
P |
9414L |
Solution concentrate for I.V. infusion 2gm (base) |
- |
- |
3,428 |
2,683,005 |
|
P |
9463C |
Solution concentrate for I.V. infusion 500mg (base) in 50mL 4 |
- |
- |
770 |
342,068 |
|
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
|||||||
VINCA ALKALOIDS AND ANALOGUES |
|||||||
L01CA01 |
VINBLASTINE SULPHATE |
||||||
P |
2199R |
Injection set containing 10mg and 10mL solvent |
- |
- |
1,270 |
173,963 |
|
P |
5989F |
Injection set containing 10mg and 10mL solvent |
- |
- |
1,407 |
71,519 |
|
L01CA02 |
VINCRISTINE SULPHATE |
||||||
P |
2374Y |
Injection set containing 1mg and 1mL solvent |
- |
- |
5,097 |
585,586 |
|
P |
5991H |
Injection set containing 1mg and 1mL solvent |
- |
- |
4,301 |
116,439 |
|
L01CA04 |
VINORELBINE |
||||||
P |
5992J |
Solution for I.V. infusion 10mg (base) in 1mL |
- |
- |
497 |
105,778 |
|
P |
5993K |
Solution for I.V. infusion 50mg (base) in 5mL |
- |
- |
1,599 |
505,211 |
|
P |
8280T |
Solution for I.V. infusion 10mg (base) in 1mL |
- |
- |
812 |
697,460 |
|
P |
8281W |
Solution for I.V. infusion 50mg (base) in 5mL |
- |
- |
1,799 |
1,592,442 |
|
P |
9009E |
Capsule 20mg (base) 20 |
- |
- |
135 |
205,332 |
|
PODOPHYLLOTOXIN DERIVATIVES |
|||||||
L01CB01 |
ETOPOSIDE |
||||||
P |
1389D |
Capsule 100mg |
- |
- |
504 |
178,884 |
|
P |
1390E |
Solution for I.V. infusion 100mg in 5mL |
- |
- |
2,980 |
470,522 |
|
P |
1396L |
Capsule 50mg |
- |
- |
700 |
286,551 |
|
P |
5931E |
Solution for I.V. infusion 100mg in 5mL |
- |
- |
801 |
67,685 |
|
P |
5932F |
Powder for I.V. infusion 100mg (as phosphate) |
- |
- |
4,751 |
379,865 |
|
P |
5933G |
Powder for I.V. infusion 1g (as phosphate) |
- |
- |
177 |
48,404 |
|
P |
8120J |
Powder for I.V. infusion 100mg (as phosphate) |
- |
- |
3,237 |
493,597 |
|
P |
8515E |
Powder for I.V. infusion 1g (as phosphate) |
- |
- |
1,958 |
617,475 |
|
P |
9010F |
Capsule 30mg,16 |
- |
- |
313 |
638,713 |
|
TAXANES |
|||||||
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
|||||||
L01CD02 |
DOCETAXEL |
||||||
P |
5270J |
Solution concentrate for I.V. infusion 20mg in 1mL 2 |
- |
- |
296 |
440,170 |
|
P |
5271K |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 |
- |
- |
370 |
481,515 |
|
P |
5272L |
Solution concentrate for I.V. infusion 80mg in 4mL 1 |
- |
- |
252 |
528,738 |
|
P |
5273M |
Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) 1 |
- |
- |
516 |
1,066,166 |
|
P |
5274N |
Solution concentrate for I.V. infusion 140mg in 7mL |
- |
- |
179 |
397,324 |
|
P |
5428Q |
Solution concentrate for I.V. infusion 20mg in 1mL 1 |
- |
- |
175 |
320,397 |
|
P |
5429R |
Solution concentrate for I.V. infusion 20mg in 2mL 1 |
- |
- |
122 |
200,002 |
|
P |
5430T |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 |
- |
- |
241 |
411,206 |
|
P |
5431W |
Solution concentrate for I.V. infusion 80mg in 4mL 1 |
- |
- |
151 |
333,820 |
|
P |
5433Y |
Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (andydrous) 1 |
- |
- |
213 |
478,311 |
|
P |
5463M |
Solution concentrate for I.V. infusion 20mg in 1mL 2 |
- |
- |
2,380 |
3,464,919 |
|
P |
5464N |
Solution concentrate for I.V. infusion 80mg in 4mL |
- |
- |
3,452 |
7,308,555 |
|
P |
5486R |
Solution concentrate for I.V. infusion 20mg in 2mL 2 |
- |
- |
771 |
1,304,260 |
|
P |
5487T |
Solution concentrate for I.V. infusion 80mg in 8mL 1 |
- |
- |
546 |
1,298,446 |
|
P |
5595L |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 |
- |
- |
114 |
57,081 |
|
P |
5596M |
Solution concentrate for I.V. infusion 80mg in 4mL 1 |
- |
- |
122 |
169,851 |
|
P |
5811W |
Solution concentrate for I.V. infusion 20mg in 1mL 2 |
- |
- |
227 |
137,803 |
|
P |
5812X |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 |
- |
- |
163 |
89,946 |
|
P |
5813Y |
Solution concentrate for I.V. infusion 80mg in 4mL 1 |
- |
- |
258 |
333,925 |
|
P |
5814B |
Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) 1 |
- |
- |
211 |
309,661 |
|
P |
5855E |
Solution concentrate for I.V. infusion 20mg in 1mL 2 |
- |
- |
360 |
206,127 |
|
P |
5856F |
Solution concentrate for I.V. infusion 80mg in 4mL 1 |
- |
- |
663 |
980,977 |
|
P |
5860K |
Solution concentrate for I.V. infusion 20mg in 2mL 2 |
- |
- |
181 |
88,793 |
|
P |
5861L |
Solution concentrate for I.V. infusion 80mg in 8mL 1 |
- |
- |
301 |
406,718 |
|
P |
5862M |
Solution concentrate for I.V. infusion 160mg in 16mL 1 |
- |
- |
252 |
582,347 |
|
P |
5864P |
Solution concentrate for I.V. infusion 20mg in 1mL 2 |
- |
- |
206 |
107,532 |
|
P |
5866R |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 |
- |
- |
270 |
158,848 |
|
P |
5867T |
Solution concentrate for I.V. infusion 80mg in 4mL 1 |
- |
- |
318 |
427,517 |
|
P |
5869X |
Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) |
- |
- |
258 |
332,770 |
|
P |
5921P |
Injection set containing I.V. infusion 20mg |
- |
- |
3,011 |
1,718,497 |
|
P |
5922Q |
Injection set containing I.V. infusion 80mg |
- |
- |
4,294 |
5,851,199 |
|
P |
8071T |
Injection set containing I.V. infusion 20mg |
- |
- |
6,524 |
10,835,714 |
|
P |
8074Y |
Injection set containing I.V. infusion 80mg |
- |
- |
7,415 |
16,431,278 |
|
P |
8967Y |
Solution concentrate for I.V. infusion 160mg in 16mL |
- |
- |
268 |
686,621 |
|
P |
8986Y |
Solution concentrate for I.V. infusion 20mg in 1mL 2 |
- |
- |
253 |
391,632 |
|
P |
8988C |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 |
- |
- |
424 |
667,458 |
|
P |
8989D |
Solution concentrate for I.V. infusion 80mg in 4mL |
- |
- |
278 |
578,351 |
|
P |
8991F |
Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) 1 |
- |
- |
448 |
881,602 |
|
P |
9291B |
Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) |
- |
- |
291 |
447,416 |
|
L01CD01 |
PACLITAXEL |
||||||
P |
3017T |
Solution for I.V. infusion 150mg in 25mL |
- |
- |
5,000 |
6,925,701 |
|
P |
3026G |
Solution for I.V. infusion 30mg in 5mL |
- |
- |
6,231 |
4,339,159 |
|
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
|||||||
P |
5847R |
Solution for I.V. infusion 100mg (base) 1 |
- |
- |
5,287 |
3,572,771 |
|
P |
5973J |
Solution for I.V. infusion 30mg in 5mL |
- |
- |
2,424 |
499,172 |
|
P |
5974K |
Solution for I.V. infusion 100mg in 16.7mL |
- |
- |
1,783 |
776,244 |
|
P |
5975L |
Solution for I.V. infusion 150mg in 25mL |
- |
- |
1,843 |
1,014,326 |
|
P |
5976M |
Solution for I.V. infusion 300mg in 50mL |
- |
- |
1,685 |
1,671,398 |
|
P |
8018B |
Solution for I.V. infusion 100mg in 16.7mL |
- |
- |
3,936 |
4,273,009 |
|
P |
8360B |
Solution for I.V. infusion 300mg in 50mL |
- |
- |
3,647 |
4,495,121 |
|
P |
9415M |
Solution for I.V. infusion 100mg (base) 1 |
- |
- |
6,464 |
12,920,905 |
|
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
|||||||
ANTHRACYCLINES AND RELATED SUBSTANCES |
|||||||
L01DB01 |
DOXORUBICIN HYDROCHLORIDE |
||||||
P |
1336H |
Solution for I.V. or intravesical 10mg |
- |
- |
702 |
22,382 |
|
P |
1340M |
Solution for I.V. or intravesical 20mg |
- |
- |
532 |
34,556 |
|
P |
1342P |
Solution for I.V. or intravesical 50mg |
- |
- |
7,919 |
772,057 |
|
P |
5879K |
Solution for I.V. or intravesical 100mg in 50mL |
- |
- |
2,967 |
172,501 |
|
P |
5880L |
Solution for I.V. or intravesical 200mg in 100mL |
- |
- |
489 |
56,856 |
|
P |
5891C |
Solution for I.V. infusion 20mg in 10mL |
- |
- |
746 |
656,631 |
|
P |
5892D |
Suspn for IV infusion 50mg in 25mL |
- |
- |
701 |
1,078,359 |
|
P |
5925W |
Solution for I.V. or intravesical 10mg |
- |
- |
532 |
6,474 |
|
P |
5926X |
Solution for I.V. or intravesical 20mg |
- |
- |
857 |
23,948 |
|
P |
5927Y |
Solution for I.V. or intravesical 50mg |
- |
- |
3,197 |
154,885 |
|
P |
8569B |
Suspn for IV infusion 20mg in 10mL |
- |
- |
1,799 |
3,692,437 |
|
P |
8570C |
Suspn for IV infusion 50mg in 25mL |
- |
- |
1,315 |
2,828,627 |
|
P |
8827N |
Solution for I.V. or intravesical 100mg in 50mL |
- |
- |
5,550 |
424,184 |
|
P |
8828P |
Solution for I.V. or intravesical 200mg in 100mL |
- |
- |
638 |
90,398 |
|
L01DB03 |
EPIRUBICIN HYDROCHLORIDE |
||||||
P |
1375J |
Solution for I.V. injection 10mg in 5mL 4 |
- |
- |
424 |
58,785 |
|
P |
1376K |
Solution for I.V. injection 20mg in 10mL 4 |
- |
- |
189 |
50,231 |
|
P |
1377L |
Solution for I.V. injection 50mg in 25mL 3 |
- |
- |
4,298 |
3,184,855 |
|
P |
5884Q |
Solution for injection 200mg in 100mL |
- |
- |
1,256 |
872,559 |
|
P |
5885R |
Solution for injection 100mg in 50mL 2 |
- |
- |
1,651 |
799,767 |
|
P |
5928B |
Solution for I.V. injection 10mg in 5mL 4 |
- |
- |
527 |
35,020 |
|
P |
5929C |
Solution for I.V. injection 20mg in 10mL 4 |
- |
- |
526 |
62,062 |
|
P |
5930D |
Solution for I.V. injection 50mg in 25mL 3 |
- |
- |
1,394 |
569,320 |
|
P |
8817C |
Solution for injection 100mg in 50mL 2 |
- |
- |
2,045 |
1,396,197 |
|
P |
8858F |
Solution for injection 200mg in 100mL |
- |
- |
1,519 |
1,219,574 |
|
L01DB06 |
IDARUBICIN HYDROCHLORIDE |
||||||
P |
8531B |
Solution for I.V. injection 10mg in 10mL |
- |
- |
135 |
247,595 |
|
L01DB07 |
MITOZANTRONE |
||||||
P |
1929M |
Injection 20mg in 10mL |
- |
- |
586 |
105,481 |
|
P |
1930N |
Injection 25mg in 12.5mL |
- |
- |
495 |
105,274 |
|
P |
5965Y |
Injection 20mg in 10mL |
- |
- |
136 |
18,973 |
|
OTHER CYTOTOXIC ANTIBIOTICS |
|||||||
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
|||||||
L01DC01 |
BLEOMYCIN |
||||||
P |
2315W |
Injection 15,000 units (solvent required) |
- |
- |
1,189 |
373,523 |
|
P |
5903Q |
Injection 15,000 units (solvent required) |
- |
- |
2,094 |
180,191 |
|
OTHER ANTINEOPLASTIC AGENTS |
|||||||
PLATINUM COMPOUNDS |
|||||||
L01XA02 |
CARBOPLATIN |
||||||
P |
1160C |
Solution for I.V. injection 50mg in 5mL |
- |
- |
1,869 |
102,413 |
|
P |
1161D |
Solution for I.V. injection 150mg in 15mL |
- |
- |
13,906 |
4,958,238 |
|
P |
1162E |
Solution for I.V. injection 450mg in 45mL |
- |
- |
8,119 |
1,871,220 |
|
P |
5906W |
Solution for I.V. injection 50mg in 5mL |
- |
- |
2,634 |
99,908 |
|
P |
5907X |
Solution for I.V. injection 150mg in 15mL |
- |
- |
6,917 |
1,005,410 |
|
P |
5908Y |
Solution for I.V. injection 450mg in 45mL |
- |
- |
6,952 |
974,981 |
|
L01XA01 |
CISPLATIN |
||||||
P |
2578Q |
I.V. injection 10mg in 10mL |
- |
- |
216 |
3,656 |
|
P |
2579R |
I.V. injection 50mg in 50mL |
- |
- |
4,307 |
144,242 |
|
P |
2580T |
I.V. injection 100mg in 100mL |
- |
- |
10,813 |
521,828 |
|
P |
5909B |
I.V. injection 10mg in 10mL |
- |
- |
138 |
782 |
|
P |
5910C |
I.V. injection 50mg in 50mL |
- |
- |
1,962 |
24,024 |
|
P |
5911D |
I.V. injection 100mg in 100mL |
- |
- |
4,198 |
138,816 |
|
L01XA03 |
OXALIPLATIN |
||||||
P |
2310N |
Powder for I.V. infusion 200mg in 40mL |
- |
- |
3,997 |
4,976,199 |
|
P |
5877H |
Solution for I.V. infusion 50mg in 10mL |
- |
- |
2,318 |
547,035 |
|
P |
5878J |
Solution for I.V. infusion 100mg in 20mL |
- |
- |
3,481 |
1,676,669 |
|
P |
5994L |
Powder for I.V. infusion 50mg |
- |
- |
1,477 |
415,028 |
|
P |
5995M |
Powder for I.V. infusion 100mg |
- |
- |
2,624 |
1,824,874 |
|
P |
5999R |
Powder for I.V. infusion 200mg in 40mL |
- |
- |
2,401 |
1,917,171 |
|
P |
8539K |
Powder for I.V. infusion 50mg |
- |
- |
5,828 |
4,932,837 |
|
P |
8540L |
Powder for I.V. infusion 100mg |
- |
- |
6,071 |
7,586,004 |
|
P |
8847P |
Solution for I.V. infusion 50mg in 10mL |
- |
- |
2,924 |
2,366,717 |
|
P |
8848Q |
Solution for I.V. infusion 100mg in 20mL |
- |
- |
3,013 |
3,262,456 |
|
MONOCLONAL ANTIBODIES |
|||||||
L01XC07 |
BEVACIZUMAB |
||||||
P |
5849W |
Soln for IV infusion 100mg/4mL |
- |
- |
5,330 |
2,987,618 |
|
P |
5850X |
Soln for IV infusion 400mg/16mL |
- |
- |
6,019 |
10,916,840 |
|
P |
9442Y |
Soln for IV infusion 100mg/4mL |
- |
- |
10,531 |
19,089,552 |
|
P |
9443B |
Soln for IV infusion 400mg/16mL |
- |
- |
12,730 |
33,671,465 |
|
L01XC06 |
CETUXIMAB |
||||||
P |
5447Q |
Solution for IV infusion 100mg in 20mL 1 |
- |
- |
878 |
2,162,802 |
|
P |
5448R |
Solution for IV infusion 500mg in 100mL 1 |
- |
- |
1,357 |
5,547,879 |
|
P |
5599Q |
Solution for IV infusion 100mg in 20mL 1 |
- |
- |
424 |
231,198 |
|
P |
5600R |
Solution for IV infusion 500mg in 100mL 1 |
- |
- |
742 |
1,370,820 |
|
P |
5836E |
Solution for IV infusion 100mg in 20mL 1 |
- |
- |
329 |
145,607 |
|
P |
5837F |
Solution for IV infusion 500mg in 100mL 1 |
- |
- |
223 |
395,560 |
|
OTHER ANTINEOPLASTIC AGENTS |
|||||||
P |
5838G |
Solution for IV infusion 100mg in 20mL 1 |
- |
- |
140 |
73,656 |
|
P |
5839H |
Solution for IV infusion 500mg in 100mL 1 |
- |
- |
367 |
671,770 |
|
P |
9136W |
Solution for IV infusion 100mg in 20mL 1 |
- |
- |
119 |
167,225 |
|
P |
9137X |
Solution for IV infusion 500mg in 100mL 1 |
- |
- |
151 |
363,311 |
|
P |
9138Y |
Solution for IV infusion 100mg in 20mL 1 |
- |
- |
270 |
459,407 |
|
P |
9139B |
Solution for IV infusion 500mg in 100mL 1 |
- |
- |
391 |
927,042 |
|
L01XC02 |
RITUXIMAB |
||||||
P |
5896H |
Solution for IV infusion 100mg\10mL |
- |
- |
5,803 |
4,496,375 |
|
P |
5897J |
Solution for IV infusion 500mg\50mL |
- |
- |
4,580 |
10,455,430 |
|
P |
5978P |
Solution for IV infusion 100mg\10mL |
- |
- |
5,078 |
4,106,134 |
|
P |
5979Q |
Solution for IV infusion 500mg\50mL |
- |
- |
4,538 |
10,317,352 |
|
P |
8293L |
Solution for IV infusion 100mg\10mL |
- |
- |
12,908 |
16,269,769 |
|
P |
8294M |
Solution for IV infusion 500mg\50mL |
- |
- |
13,316 |
33,726,683 |
|
P |
8665C |
Solution for IV infusion 100mg\10mL |
- |
- |
11,019 |
14,375,934 |
|
P |
8666D |
Solution for IV infusion 500mg\50mL |
- |
- |
10,752 |
26,820,525 |
|
P |
9611W |
Solution for IV infusion 500mg\50mL |
- |
- |
738 |
3,360,435 |
|
L01XC03 |
TRASTUZUMAB |
||||||
P |
6497Y |
Powder for IV infusion 150mg |
- |
- |
9,762 |
33,220,609 |
|
P |
9691C |
Powder for IV infusion 60mg |
- |
- |
3,750 |
7,950,331 |
|
PROTEIN KINASE INHIBITORS |
|||||||
L01XE06 |
DASATINIB |
||||||
P |
2482P |
Tablet 50mg 60 |
- |
- |
483 |
2,569,222 |
|
P |
2485T |
Tablet 70mg 60 |
- |
- |
227 |
1,454,307 |
|
P |
9283N |
Tablet 50mg 60 |
- |
- |
183 |
966,843 |
|
P |
9341P |
Tablet 100mg 60 |
- |
- |
434 |
2,306,718 |
|
P |
9342Q |
Tablet 100mg 60 |
- |
- |
486 |
2,559,750 |
|
L01XE03 |
ERLOTINIB |
||||||
P |
9166K |
Tablet 25mg (as hydrochloride) 30 |
- |
- |
426 |
575,934 |
|
P |
9167L |
Tablet 100mg (as hydrochloride) 30 |
- |
- |
1,553 |
4,224,266 |
|
P |
9168M |
Tablet 150mg (as hydrochloride) 30 |
- |
- |
4,704 |
15,790,000 |
|
L01XE02 |
GEFITINIB |
||||||
P |
8769M |
Tablet 250mg 30 |
- |
- |
383 |
1,492,942 |
|
L01XE01 |
IMATINIB |
||||||
P |
5444M |
Tablet 400mg (as mesylate) 30 |
- |
- |
135 |
529,574 |
|
P |
9111M |
Tablet 100mg (base) 60 |
- |
- |
718 |
2,091,988 |
|
P |
9112N |
Tablet 400mg (base) 30 |
- |
- |
2,901 |
11,516,541 |
|
P |
9113P |
Tablet 100mg (base) 60 |
- |
- |
5,381 |
20,245,598 |
|
P |
9114Q |
Tablet 400mg (base) 30 |
- |
- |
13,733 |
57,487,362 |
|
P |
9115R |
Tablet 100mg (base) 60 |
- |
- |
502 |
2,126,859 |
|
P |
9116T |
Tablet 400mg (base) 30 |
- |
- |
892 |
4,402,203 |
|
P |
9123E |
Tablet 100mg (base) 60 |
- |
- |
247 |
725,124 |
|
P |
9124F |
Tablet 400mg (base) 30 |
- |
- |
214 |
878,778 |
|
L01XE07 |
LAPATINIB |
||||||
OTHER ANTINEOPLASTIC AGENTS |
|||||||
P |
9148L |
Tablet 250mg 140 |
- |
- |
1,615 |
5,444,098 |
|
L01XE08 |
NILOTINIB |
||||||
P |
9171Q |
Capsule 200mg (as hydrochloride monohydrate) 112 |
- |
- |
1,031 |
5,656,562 |
|
P |
9285Q |
Capsule 200mg (as hydrochloride monohydrate) 112 |
- |
- |
608 |
3,343,816 |
|
L01XE05 |
SORAFENIB |
||||||
P |
9380Q |
Tablet 200mg (as tosylate) 120 |
- |
- |
1,377 |
8,889,156 |
|
L01XE04 |
SUNITINIB |
||||||
P |
9417P |
Capsule 12.5mg (as malate) 28 |
- |
- |
170 |
322,837 |
|
P |
9418Q |
Capsule 25mg (as malate) 28 |
- |
- |
280 |
1,010,356 |
|
P |
9419R |
Capsule 50mg (as malate) 28 |
- |
- |
542 |
3,822,448 |
|
P |
9420T |
Capsule 12.5mg (as malate) 28 |
- |
- |
1,332 |
2,702,163 |
|
P |
9421W |
Capsule 25mg (as malate) 28 |
- |
- |
2,125 |
7,574,434 |
|
P |
9422X |
Capsule 50mg (as malate) 28 |
- |
- |
1,119 |
7,796,750 |
|
P |
9489K |
Capsule 25mg (as malate) 28 |
- |
- |
154 |
548,232 |
|
P |
9490L |
Capsule 50mg (as malate) 28 |
- |
- |
121 |
842,049 |
|
OTHER ANTINEOPLASTIC AGENTS |
|||||||
L01XX27 |
ARSENIC TRIOXIDE |
||||||
P |
5851Y |
Injection concentrate 10mg in 10mL 60 |
- |
- |
113 |
133,475 |
|
L01XX32 |
BORTEZOMIB |
||||||
P |
5488W |
Powder for inject 3.5mg (solvent required) 4 |
- |
- |
186 |
1,348,180 |
|
P |
9117W |
Powder for injection 3.5mg (solvent required) 4 |
- |
- |
1,961 |
14,223,459 |
|
P |
9118X |
Powder for injection 3.5mg (solvent required) 4 |
- |
- |
149 |
1,072,305 |
|
L01XX05 |
HYDROXYUREA |
||||||
P |
3093T |
Capsule 500mg |
- |
- |
36,148 |
2,783,999 |
|
L01XX19 |
IRINOTECAN |
||||||
P |
5833B |
I V injection 500mg in 25mL |
- |
- |
796 |
598,920 |
|
P |
5846Q |
I V injection 300mg in 15mL |
- |
- |
1,376 |
688,605 |
|
P |
5958N |
I V injection 40mg in 2mL |
- |
- |
1,968 |
149,229 |
|
P |
5959P |
I V injection 100mg in 5mL |
- |
- |
3,438 |
1,021,147 |
|
P |
8414W |
I V injection 40mg in 2mL |
- |
- |
2,054 |
517,565 |
|
P |
8415X |
I V injection 100mg in 5mL |
- |
- |
4,780 |
3,010,911 |
|
P |
9119Y |
I V injection 500mg in 25mL |
- |
- |
1,751 |
1,589,124 |
|
P |
9410G |
I V injection 300mg in 15mL |
- |
- |
4,825 |
2,964,728 |
|
L01XX17 |
TOPOTECAN |
||||||
P |
5985B |
Powder for I.V. infusion 4mg (base) |
- |
- |
127 |
135,036 |
|
P |
8199M |
Powder for I.V. infusion 4mg (base) |
- |
- |
311 |
629,204 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||||
L02AB02 |
MEDROXYPROGESTERONE |
||||||
P |
2316X |
Tablet 200mg |
1000.00 |
MG |
1,575 |
159,597 |
|
P |
2725K |
Tablet 100mg |
1000.00 |
MG |
1,982 |
179,175 |
|
P |
2727M |
Tablet 250mg |
1000.00 |
MG |
169 |
21,212 |
|
P |
2728N |
Tablet 500mg |
1000.00 |
MG |
650 |
81,771 |
|
L02AB01 |
MEGESTROL |
||||||
P |
2734X |
Tablet 160mg |
160.00 |
MG |
1,271 |
106,074 |
|
GONADOTROPHIN RELEASING HORMONE ANALOGUES |
|||||||
L02AE03 |
GOSERELIN |
||||||
P |
1454M |
Subcutaneous implant 3.6mg |
0.13 |
MG |
20,890 |
6,939,702 |
|
P |
8093Y |
Subcutaneous implant 10.8mg (base) in prefilled injection syringe |
0.13 |
MG |
47,349 |
52,496,206 |
|
P |
9064C |
Subcutaneous implant 3.6mg (base) in prefilled injection syringe and 28 tabs 50mg |
0.13 |
MG |
381 |
181,975 |
|
P |
9065D |
Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 28 tabs 50mg |
0.13 |
MG |
819 |
1,025,021 |
|
P |
9066E |
Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 84 tabs 50mg |
0.13 |
MG |
3,455 |
5,280,311 |
|
L02AE02 |
LEUPRORELIN ACETATE |
||||||
A |
14727 |
Injection 5mg |
0.13 |
MG |
2,684 |
- |
|
P |
8707G |
Suspn subcutaneous inj (mod rel) 7.5mg inj set |
0.13 |
MG |
637 |
267,649 |
|
P |
8708H |
Suspn subcutaneous inj (mod rel) 22.5mg inj set |
0.13 |
MG |
4,109 |
4,554,956 |
|
P |
8709J |
Suspn subcutaneous inj (mod rel) 30mg inj set |
0.13 |
MG |
1,012 |
1,468,872 |
|
P |
8859G |
Suspn subcutaneous inj (mod rel) 45mg inj set |
0.13 |
MG |
3,236 |
6,890,624 |
|
P |
8875D |
I.M. injection (modified release) 7.5mg diluent |
0.13 |
MG |
3,457 |
1,452,363 |
|
P |
8876E |
I.M. injection (modified release) 22.5mg diluent |
0.13 |
MG |
14,271 |
15,821,745 |
|
P |
8877F |
I.M. injection (modified release) 30mg diluent |
0.13 |
MG |
9,171 |
13,318,173 |
|
L02AE04 |
TRIPTORELIN |
||||||
P |
9379P |
Powder for I.M. injection (prolonged release) 11.25mg (as embonate) with solvent, syringe and needles |
0.13 |
MG |
363 |
402,478 |
|
HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||||
ANTI-ESTROGENS |
|||||||
L02BA01 |
TAMOXIFEN |
||||||
P |
2109B |
Tablet 10mg (base) 60 |
20.00 |
MG |
2,570 |
95,355 |
|
P |
2110C |
Tablet 20mg (base) 60 |
20.00 |
MG |
123,685 |
7,108,053 |
|
L02BA02 |
TOREMIFENE |
||||||
P |
8216K |
Tablet 60mg (base) |
60.00 |
MG |
1,550 |
114,201 |
|
ANTI-ANDROGENS |
|||||||
L02BB03 |
BICALUTAMIDE |
||||||
P |
8094B |
Tablet 50mg |
50.00 |
MG |
39,147 |
6,268,681 |
|
L02BB01 |
FLUTAMIDE |
||||||
P |
1417N |
Tablet 250mg |
750.00 |
MG |
1,987 |
399,937 |
|
L02BB02 |
NILUTAMIDE |
||||||
P |
8131Y |
Tablet 150mg |
30.00 |
MG |
4,693 |
1,124,014 |
|
AROMATASE INHIBITORS |
|||||||
L02BG03 |
ANASTROZOLE |
||||||
P |
8179L |
Tablet 1mg |
1.00 |
MG |
215,668 |
38,827,728 |
|
HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||||
L02BG06 |
EXEMESTANE |
||||||
P |
8506Q |
Tablet 25mg 30 |
25.00 |
MG |
24,287 |
4,067,637 |
|
L02BG04 |
LETROZOLE |
||||||
P |
8245Y |
Tablet 2.5mg |
2.50 |
MG |
139,035 |
25,025,780 |
|
OTHER HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||||
L02BX02 |
DEGARELIX |
||||||
P |
5455D |
Powder for injection 80mg (as acetate) with solvent, syringe and needles 2 1 |
2.70 |
MG |
707 |
298,666 |
|
P |
5456E |
Powder for injection 120mg (as acetate) with solvent, syringe and needles 2 1 |
2.70 |
MG |
171 |
75,439 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||||
L03AA02 |
FILGRASTIM |
||||||
P |
6126K |
Injection 300ug in 1mL 20 |
0.35 |
MG |
135 |
211,380 |
|
P |
6291D |
Injection 300ug in 0.5mL 20 |
0.35 |
MG |
2,014 |
3,726,573 |
|
P |
6292E |
Injection 480ug in 0.5mL 20 |
0.35 |
MG |
812 |
3,407,194 |
|
L03AA13 |
PEGFILGRASTIM |
||||||
P |
6363X |
Injection 6mg in 0.6mL single use syringe |
0.30 |
MG |
17,242 |
35,310,849 |
|
INTERFERONS |
|||||||
L03AB07 |
INTERFERON BETA-1a |
||||||
P |
8289G |
Inj. set 1 vial powder dose 30ug (6,000,000iu) |
4.30 |
UG |
1,937 |
2,046,761 |
|
P |
8403G |
Injection 44ug (12,000,000iu) in 0.5mL single syringe |
4.30 |
UG |
12,004 |
12,679,048 |
|
P |
8805K |
Injection 30ug (6,000,000iu) in 0.5mL single syringe |
4.30 |
UG |
18,843 |
19,912,194 |
|
P |
8968B |
Injection 44ug (12,000,000iu) in 0.5mL syringe dose auto injector |
4.30 |
UG |
599 |
629,949 |
|
P |
9332E |
Solution for injection 132ug in 1.5mL multidose cartridge 4 |
4.30 |
UG |
6,511 |
7,026,974 |
|
L03AB08 |
INTERFERON BETA-1b |
||||||
P |
8101J |
Injection set 1 vial powder dose 8,000,000iu |
4.00 |
ME |
28,972 |
34,195,002 |
|
L03AB04 |
INTERFERON-ALFA-2a |
||||||
P |
8180M |
Solution for injection 3,000,000iu in 0.5mL 15 |
2.00 |
ME |
1,441 |
791,336 |
|
P |
8181N |
Solution for injection 3,000,000iu in 0.5mL 15 |
2.00 |
ME |
173 |
90,955 |
|
P |
8551C |
Injection 45,000,000iu in 0.5mL syringe 5 |
2.00 |
ME |
170 |
113,228 |
|
L03AB05 |
INTERFERON-ALFA-2b |
||||||
P |
8348J |
Solution for injection 18,000,000iu in 1.2mL multi-dose pen 3 |
2.00 |
ME |
227 |
143,433 |
|
L03AB11 |
PEGINTERFERON ALFA-2a |
||||||
P |
6449K |
Prefilled syringe 180ug/0.5mL 8 |
26.00 |
UG |
499 |
839,165 |
|
L03AB61 |
RIBAVIRIN and PEGINTERFERON ALFA-2a |
||||||
P |
6394M |
112 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 |
- |
- |
366 |
658,626 |
|
P |
6395N |
140 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 |
- |
- |
702 |
1,438,690 |
|
P |
6396P |
168 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 |
- |
- |
729 |
1,636,500 |
|
L03AB60 |
RIBAVIRIN and PEGINTERFERON ALFA-2b |
||||||
P |
6405D |
112 ribavirin 200mg/4 single use injection pens 2 |
- |
- |
186 |
321,435 |
|
P |
6407F |
140 ribavirin 200mg/4 single use injection pens 2 |
- |
- |
311 |
565,284 |
|
P |
6410J |
168 ribavirin 200mg/4 single use injection pens 2 |
- |
- |
120 |
270,599 |
|
OTHER IMMUNOSTIMULANTS |
|||||||
L03AX03 |
BCG VACCINE |
||||||
P |
1131M |
Vial powder for intravesical admin. 5x10^8 CFU |
- |
- |
1,846 |
1,007,333 |
|
P |
1140B |
Injection set 1 vial Powder |
- |
- |
1,627 |
561,047 |
|
P |
5901N |
Injection set 1 vial Powder |
- |
- |
1,086 |
227,070 |
|
P |
5902P |
Ampoule containing powder 5x10^8 CFU |
- |
- |
274 |
54,920 |
|
L03AX13 |
GLATIRAMER ACETATE |
||||||
P |
8726G |
Inj 20mg in 1mL single dose prefilled syringe |
20.00 |
MG |
26,389 |
28,830,836 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||||
L04AA24 |
ABATACEPT |
||||||
P |
9621J |
Powder for I.V. infusion 250mg |
27.00 |
MG |
4,187 |
6,761,459 |
|
L04AA18 |
EVEROLIMUS |
||||||
P |
8840G |
Tablet 0.25mg 60 |
1.50 |
MG |
200 |
61,174 |
|
P |
8841H |
Tablet 0.5mg 60 |
1.50 |
MG |
767 |
556,187 |
|
P |
8842J |
Tablet 0.75mg 120 |
1.50 |
MG |
420 |
647,017 |
|
P |
9352F |
Tablet 1mg 120 |
1.50 |
MG |
129 |
283,404 |
|
L04AA27 |
FINGOLIMOD |
||||||
P |
5262Y |
Capsule 500ug (as hydrochloride) 28 |
0.50 |
MG |
5,189 |
12,013,373 |
|
L04AA13 |
LEFLUNOMIDE |
||||||
P |
5449T |
Tablet 10mg 30 |
20.00 |
MG |
4,347 |
334,388 |
|
P |
5450W |
Tablet 20mg 30 |
20.00 |
MG |
8,257 |
938,025 |
|
P |
8374R |
Tablet 10mg 30 |
20.00 |
MG |
52,418 |
4,488,435 |
|
P |
8375T |
Tablet 20mg 30 |
20.00 |
MG |
117,464 |
14,856,128 |
|
L04AA06 |
MYCOPHENOLIC ACID |
||||||
P |
6208R |
Capsule 250mg 600 |
2.00 |
GM |
277 |
113,944 |
|
P |
6209T |
Tablet 500mg 300 |
2.00 |
GM |
1,238 |
960,706 |
|
P |
6370G |
Tablet (enteric coated) 360mg 240 |
2.00 |
GM |
246 |
168,452 |
|
P |
8649F |
Capsule 250mg 300 |
2.00 |
GM |
1,495 |
888,473 |
|
P |
8650G |
Capsule 500mg 150 |
2.00 |
GM |
10,106 |
6,512,489 |
|
P |
8652J |
Tablet (enteric coated) 180mg 120 |
2.00 |
GM |
364 |
103,515 |
|
P |
8653K |
Tablet (enteric coated) 360mg 120 |
2.00 |
GM |
1,832 |
934,495 |
|
L04AA23 |
NATALIZUMAB |
||||||
P |
9624M |
Sol.concentrate for I.V. infusion 300mg in 15mL |
10.00 |
MG |
4,756 |
9,967,651 |
|
L04AA10 |
SIROLIMUS |
||||||
P |
8724E |
Tablet 1mg 100 |
3.00 |
MG |
449 |
383,651 |
|
P |
8833X |
Tablet 2mg 100 |
3.00 |
MG |
199 |
324,800 |
|
TUMOR NECROSIS FACTOR ALPHA INHIBITORS |
|||||||
L04AB04 |
ADALIMUMAB |
||||||
P |
8737W |
Injection 40mg in 0.8mL prefilled syringe |
2.90 |
MG |
1,323 |
2,344,912 |
|
P |
8741C |
Injection 40mg in 0.8mL prefilled syringe |
2.90 |
MG |
12,063 |
21,386,484 |
|
P |
8963R |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
119 |
211,400 |
|
P |
8964T |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
119 |
210,847 |
|
P |
8965W |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
250 |
442,106 |
|
P |
8966X |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
368 |
651,801 |
|
P |
9033K |
Injection 40mg in 0.8mL prefilled syringe |
2.90 |
MG |
351 |
622,874 |
|
P |
9034L |
Injection 40mg in 0.8mL prefilled syringe |
2.90 |
MG |
2,697 |
4,785,378 |
|
P |
9077R |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
332 |
589,088 |
|
P |
9078T |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
2,901 |
5,141,488 |
|
P |
9099X |
Injection 40mg in 0.8mL prefilled syringe |
2.90 |
MG |
4,799 |
8,516,055 |
|
P |
9100Y |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
30,176 |
53,528,847 |
|
P |
9101B |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
1,522 |
2,697,221 |
|
IMMUNOSUPPRESSANTS |
|||||||
P |
9102C |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
9,370 |
16,624,137 |
|
P |
9103D |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
1,763 |
3,129,872 |
|
P |
9104E |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
10,140 |
17,990,941 |
|
P |
9186L |
Injection 40mg in 0.8mL prefilled syringe 6 |
2.90 |
MG |
203 |
1,033,332 |
|
P |
9187M |
Injection 40mg in 0.8mL prefilled pen 6 |
2.90 |
MG |
557 |
2,833,101 |
|
P |
9188N |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
539 |
954,746 |
|
P |
9189P |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
4,019 |
7,133,256 |
|
P |
9190Q |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
1,679 |
2,980,579 |
|
P |
9191R |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
11,212 |
19,900,161 |
|
P |
9425C |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
728 |
1,291,356 |
|
P |
9426D |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
875 |
1,552,187 |
|
P |
9427E |
Injection 40mg in 0.8mL prefilled syringe 2 |
2.90 |
MG |
3,634 |
6,443,237 |
|
P |
9428F |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
4,439 |
7,871,173 |
|
P |
9680L |
Injection 40mg in 0.8mL prefilled pen 2 |
2.90 |
MG |
127 |
212,905 |
|
L04AB05 |
CERTOLIZUMAB PEGOL |
||||||
P |
3425G |
Injection 200mg in 1mL single use prefilled syringe 1 |
14.00 |
MG |
4,286 |
7,320,227 |
|
L04AB01 |
ETANERCEPT |
||||||
P |
3449M |
Injection 50mg in 1 mL single use prefilled syringes 4 1 |
7.00 |
MG |
240 |
425,849 |
|
P |
6367D |
Injection set 4 vial pdr 25mg and 4 syringe solvent |
7.00 |
MG |
469 |
793,614 |
|
P |
8637N |
Injection set 4 vial pdr 25mg and 4 syringe solvent |
7.00 |
MG |
112 |
204,848 |
|
P |
8638P |
Injection set 4 vial pdr 25mg and 4 syringe solvent |
7.00 |
MG |
2,547 |
4,697,721 |
|
P |
8779C |
Injection set 4 vial pdr 25mg and 4 syringe solvent |
7.00 |
MG |
743 |
1,348,012 |
|
P |
9036N |
Injection set 4 vial pdr 25mg and 4 syringe solvent |
7.00 |
MG |
345 |
637,320 |
|
P |
9085E |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
375 |
666,395 |
|
P |
9086F |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
4,839 |
8,586,405 |
|
P |
9087G |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
276 |
489,763 |
|
P |
9088H |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
3,083 |
5,470,293 |
|
P |
9089J |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
1,080 |
1,916,576 |
|
P |
9090K |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
19,164 |
34,020,613 |
|
P |
9091L |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
123 |
218,394 |
|
P |
9431J |
Injection 50mg in 1mL single use prefilled syr, 4 |
7.00 |
MG |
2,364 |
4,195,387 |
|
P |
9455P |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
922 |
1,636,115 |
|
P |
9456Q |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
5,097 |
9,044,217 |
|
P |
9457R |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
901 |
1,609,315 |
|
P |
9458T |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
4,133 |
7,338,944 |
|
P |
9459W |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
3,669 |
6,522,988 |
|
P |
9460X |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
19,266 |
34,216,717 |
|
P |
9461Y |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
286 |
507,580 |
|
P |
9462B |
Injection 50mg in 1mL single use auto injector, 4 |
7.00 |
MG |
1,311 |
2,326,309 |
|
L04AB06 |
GOLIMUMAB |
||||||
P |
3426H |
Injection 50mg in 0.5mL single use prefilled syringe 1 |
1.66 |
MG |
1,933 |
3,439,093 |
|
P |
3427J |
Injection 50mg in 0.5mL single use prefilled pen 1 |
1.66 |
MG |
814 |
1,446,714 |
|
P |
3428K |
Injection 50mg in 0.5mL single use prefilled syringe 1 |
1.66 |
MG |
4,999 |
8,886,932 |
|
IMMUNOSUPPRESSANTS |
|||||||
P |
3429L |
Injection 50mg in 0.5mL single use prefilled pen 1 |
1.66 |
MG |
1,094 |
1,944,975 |
|
P |
3430M |
Injection 50mg in 0.5mL single use prefilled syringe 1 |
1.66 |
MG |
811 |
1,441,488 |
|
P |
3431N |
Injection 50mg in 0.5mL single use prefilled pen 1 |
1.66 |
MG |
338 |
600,724 |
|
P |
3432P |
Injection 50mg in 0.5mL single use prefilled syringe 1 |
1.66 |
MG |
1,884 |
3,348,316 |
|
P |
3433Q |
Injection 50mg in 0.5mL single use prefilled pen 1 |
1.66 |
MG |
395 |
702,004 |
|
P |
3434R |
Injection 50mg in 0.5mL single use prefilled syringe 1 |
1.66 |
MG |
857 |
1,523,376 |
|
P |
3435T |
Injection 50mg in 0.5mL single use prefilled pen 1 |
1.66 |
MG |
337 |
598,984 |
|
P |
3436W |
Injection 50mg in 0.5mL single use prefilled syringe 1 |
1.66 |
MG |
2,235 |
3,972,129 |
|
P |
3437X |
Injection 50mg in 0.5mL single use prefilled pen 1 |
1.66 |
MG |
662 |
1,176,644 |
|
L04AB02 |
INFLIXIMAB |
||||||
P |
6397Q |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
762 |
1,815,776 |
|
P |
6448J |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
1,700 |
5,963,451 |
|
P |
6496X |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
469 |
1,738,274 |
|
P |
9612X |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
146 |
365,897 |
|
P |
9613Y |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
2,145 |
6,830,885 |
|
P |
9617E |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
237 |
907,593 |
|
P |
9674E |
Powder for I.V. infusion 100mg 1 |
3.75 |
MG |
409 |
1,309,432 |
|
INTERLEUKIN INHIBITORS |
|||||||
L04AC07 |
TOCILIZUMAB |
||||||
P |
9671B |
Concentrate for injection 80mg in 4mL 1 |
20.00 |
MG |
4,177 |
1,842,260 |
|
P |
9672C |
Concentrate for injection 200mg in 10mL 1 |
20.00 |
MG |
1,907 |
1,089,461 |
|
P |
9673D |
Concentrate for injection 400mg in 20mL 1 |
20.00 |
MG |
5,785 |
6,953,210 |
|
L04AC05 |
USTEKINUMAB |
||||||
P |
9304Q |
Injection 45mg in 0.5mL |
0.54 |
MG |
1,177 |
7,168,538 |
|
P |
9305R |
Injection 45mg in 0.5mL |
0.54 |
MG |
1,677 |
10,973,299 |
|
CALCINEURIN INHIBITORS |
|||||||
L04AD01 |
CYCLOSPORIN |
||||||
P |
6232B |
Capsule 10mg (with microemulsion pre-concentrate) 120 |
0.25 |
GM |
300 |
24,462 |
|
P |
6352H |
Capsule 25mg 120 |
0.25 |
GM |
1,316 |
225,401 |
|
P |
6353J |
Capsule 50mg 120 |
0.25 |
GM |
1,129 |
341,608 |
|
P |
6354K |
Capsule 100mg 120 |
0.25 |
GM |
1,479 |
790,970 |
|
P |
8657P |
Capsule 10mg 120 |
0.25 |
GM |
1,375 |
157,800 |
|
P |
8658Q |
Capsule 25mg 60 |
0.25 |
GM |
8,495 |
1,133,815 |
|
P |
8659R |
Capsule 50mg 60 |
0.25 |
GM |
12,520 |
2,712,630 |
|
P |
8660T |
Capsule 100mg 60 |
0.25 |
GM |
11,810 |
4,946,983 |
|
P |
8661W |
Oral liquid 100mg per mL |
0.25 |
GM |
277 |
172,128 |
|
L04AD02 |
TACROLIMUS |
||||||
P |
5299X |
Capsule 0.5mg 30 |
5.00 |
MG |
279 |
22,491 |
|
P |
5300Y |
Capsule 1mg (once daily prolonged release) 60 |
5.00 |
MG |
598 |
192,468 |
|
P |
5451X |
Capsule 5mg (once daily prolonged release) 30 |
5.00 |
MG |
181 |
131,977 |
|
P |
6216E |
Capsule 1mg 200 |
5.00 |
MG |
849 |
612,132 |
|
P |
6328C |
Capsule 500ug 200 |
5.00 |
MG |
208 |
48,202 |
|
P |
8646C |
Capsule 500ug 100 |
5.00 |
MG |
3,956 |
795,524 |
|
IMMUNOSUPPRESSANTS |
|||||||
P |
8647D |
Capsule 1mg 100 |
5.00 |
MG |
11,221 |
6,242,627 |
|
P |
8648E |
Capsule 5mg 100 |
5.00 |
MG |
528 |
754,499 |
|
OTHER IMMUNOSUPPRESSANTS |
|||||||
L04AX01 |
AZATHIOPRINE |
||||||
P |
2687K |
Tablet 50mg |
0.15 |
GM |
148,416 |
8,179,191 |
|
P |
2688L |
Tablet 25mg |
0.15 |
GM |
17,053 |
604,414 |
|
L04AX04 |
LENALIDOMIDE |
||||||
P |
9643M |
Capsule 10mg 21 |
10.00 |
MG |
494 |
2,907,307 |
|
P |
9644N |
Capsule 15mg 21 |
10.00 |
MG |
586 |
3,883,781 |
|
P |
9645P |
Capsule 25mg 21 |
10.00 |
MG |
1,234 |
8,613,410 |
|
L04AX02 |
THALIDOMIDE |
||||||
P |
6469L |
Capsules 50mg 112 |
0.10 |
GM |
2,820 |
3,103,418 |
|
P |
9684Q |
Capsules 100mg 56 |
0.10 |
GM |
1,129 |
1,571,458 |